Dow Down 0.11% Nasdaq Up 0.31%

CytRx Corporation (CYTR)

-NasdaqCM
3.27 Down 0.05(1.51%) 10:14AM EDT - Nasdaq Real Time Price
Prev Close:3.32
Open:3.33
Bid:3.29 x 4800
Ask:3.30 x 300
1y Target Est:11.00
Beta:1.06
Next Earnings Date:N/A
Day's Range:3.26 - 3.35
52wk Range:2.00 - 8.35
Volume:117,985
Avg Vol (3m):1,355,570
Market Cap:182.30M
P/E (ttm):N/A
EPS (ttm):-0.95
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CYTR

Comparison

Symbol% ChgMkt Cap
CYTRDown 1.51%182.30M
LLYDown 0.05%68.09B
NVSUp 3.47%225.54B
SNYUp 0.38%144.10B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):1,850.90
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.70
Quarterly EPS Est (Sep-14) :-0.25
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate includes aldoxorubicin that has completed Phase IIb clinical trial as a first-line therapy for soft t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback